Startup Programs

Startup programs

Startup biotech companies face many challenges in the quest to push the next generation of drugs to market. Your promising molecule requires resources and support to realize its potential. To accelerate to clinic faster, you can connect with a variety of startup programs, grants, funding sources, and industry resources.

Emerging Biotech Grant Programs

The Advance Biotech Grant Program is offered by us on a regular basis in different regions of the world. The program allows grant recipients to receive in-kind products and consultation support to advance production. Since 2014, the Advance Biotech Grants have been awarded to more than 28 biotechnology companies, supporting missions that include helping patients suffering from cancer, brain tumors, osteoarthritis, and cardiovascular disorders. You can review the official rules to learn more or register to receive grant and event information.



Emerging BioTalk - pathways for pioneers

Connecting with other biotech professionals

In an industry where information and relationships are as vital as funding, you must be able to network. One venue for biotech startups is Emerging Biotalk, an online forum where biotechnology professionals can discuss and exchange ideas. Industry news, blog posts, and grant information help you connect with other experts and entrepreneurs, in order to solve challenges and discover new opportunities.

The right resources allow you to focus on discovering innovations that may help patients in need. Select any stage of the development process to learn more. Or follow the product and service links for supportive resources offering plug-and-play opportunities at the beginning of your startup creation.

Funding

Lack of funding is one of the main reasons for failure of a biologic. Estimates vary, but some project that it costs $8–10 million just to get to the IND stage, another $8–10 million for Phase I, and $20–40 million for Phase II, depending on design. Phase III costs considerably more. There are ways to fund biotech, from biotech crowdfunding, nondilutive funding, and noncoercive funding, to biotech grants, angel investors, venture capital and other resources. Here are some good starting points in your search for funding.

  • M Ventures, Amsterdam, The Netherlands, a subsidiary of Merck KGaA, Darmstadt, Germany is a venture fund that joins forces with industry visionaries to maintain science and technology leadership for the next generation
  • Merck KGaA, Darmstadt, Germany offers a wide range of grants and awards for pharmaceutical and biopharmaceutical research
  • EMD Serono Partners provides scientists and engineers with best-in-class lab materials, technologies, and services that accelerate access to health for people everywhere
  • The Bill & Melinda Gates Foundation awards grants primarily to U.S. 501(c)(3) organizations and other tax-exempt organizations
  • Grants.gov provides a listing of available federal grants

Startup biotech companies face many challenges in the quest to push the next generation of drugs to market. Your promising molecule requires resources and support to realize its potential. To accelerate to clinic faster, you can connect with a variety of startup programs, grants, funding sources, and industry resources.


Biotech Hub Resources Workflow

Biotech Resource Hub

Biotech Resource Hub

Starting your journey to successful drug discovery, development, and commercialization

Discovery

Identifying the considerations, resources, and support you need to develop a new biologics candidate

Pre-clinical

Establishing safety and effectiveness for your Investigational New Drug (IND) application

Phase I–II

Accelerating your process development with tips, templates, and application guides

Phase III and Manufacturing

Progressing from scale-up and tech transfer to quality production for trials and commercialization

Regulatory

Navigating one of the world’s most regulated industries starts with a trusted guide